(Total Views: 615)
Posted On: 11/09/2025 2:47:00 PM
Post# of 158772
"So you are saying in a year or two, we might consider a new CEO."
No, I said after FDA approval there could very well be a CEO change.
JL and the BOD have assembled a widely experienced and successful group of professionals to shepherd leronlimab to humanity. CYDY is not their first rodeo by far. Please go to their website and read the biographies of the people involved with CYDY. Ask yourself why such a group as the leadership team, BOD and Advisory Board all would come together to work for a tiny, heretofore backwards biotech company? For some of these people it is to get a pretty special molecule out into the clinical world. For others it is to ensure that CYDY will become both financially and medically successful.
CYDY may very well not exist sometime after leronlimab gains FDA approval. The team that is currently CYDY will determine if it would remain as an independent company or be absorbed by the winner of the Big Pharma auction.
I don't know what will happen in the future, but do know that first things first: get FDA approval for leronlimab while ensuring that leronlimab will be available to all who need it in a very financially stable situation- which is what we longs are also very interested in seeing through.
Big Pharma knows about leronlimab as that has been the job for some of the CYDY group. Nobody in Big Pharma or CYDY is going to talk about interest in leronlimab publicly until there are human results from human trials that define leronlimab's MOA and those results That is what is happening now.
CYDY is finally on a very good trajectory. Because of all that has occurred since the FDA finally lifted its protracted hold it is clear that CYDY is not now broken.
So don't try to fix it by a distracting CEO change, unless Scott Gottlieb or Margaret Hamburg are available!
No, I said after FDA approval there could very well be a CEO change.
JL and the BOD have assembled a widely experienced and successful group of professionals to shepherd leronlimab to humanity. CYDY is not their first rodeo by far. Please go to their website and read the biographies of the people involved with CYDY. Ask yourself why such a group as the leadership team, BOD and Advisory Board all would come together to work for a tiny, heretofore backwards biotech company? For some of these people it is to get a pretty special molecule out into the clinical world. For others it is to ensure that CYDY will become both financially and medically successful.
CYDY may very well not exist sometime after leronlimab gains FDA approval. The team that is currently CYDY will determine if it would remain as an independent company or be absorbed by the winner of the Big Pharma auction.
I don't know what will happen in the future, but do know that first things first: get FDA approval for leronlimab while ensuring that leronlimab will be available to all who need it in a very financially stable situation- which is what we longs are also very interested in seeing through.
Big Pharma knows about leronlimab as that has been the job for some of the CYDY group. Nobody in Big Pharma or CYDY is going to talk about interest in leronlimab publicly until there are human results from human trials that define leronlimab's MOA and those results That is what is happening now.
CYDY is finally on a very good trajectory. Because of all that has occurred since the FDA finally lifted its protracted hold it is clear that CYDY is not now broken.
So don't try to fix it by a distracting CEO change, unless Scott Gottlieb or Margaret Hamburg are available!
(8)
(0)
